PCM
PETS icon

Penserra Capital Management’s PetMed Express PETS Stock Holding History

Penserra Capital Management’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-267,108
Closed -$3.68M – 1338
2023
Q2 		$3.68M Buy
267,108
+63,082
+31% +$947K 0.07% 188
2023
Q1 		$3.31M Sell
204,026
-13,452
-6% -$253K 0.07% 203
2022
Q4 		$3.85M Sell
217,478
-25,893
-11% -$514K 0.08% 167
2022
Q3 		$4.75M Sell
243,371
-19,464
-7% -$413K 0.13% 131
2022
Q2 		$5.23M Sell
262,835
-76,021
-22% -$1.7M 0.14% 131
2022
Q1 		$8.74M Sell
338,856
-78,840
-19% -$2.04M 0.21% 112
2021
Q4 		$10.6M Sell
417,696
-191,659
-31% -$5.3M 0.23% 122
2021
Q3 		$16.4M Sell
609,355
-133,385
-18% -$3.84M 0.34% 80
2021
Q2 		$23.7M Sell
742,740
-243,656
-25% -$7.74M 0.43% 62
2021
Q1 		$34.7M Buy
986,396
+55,410
+6% +$1.93M 0.64% 42
2020
Q4 		$29.8M Buy
930,986
+412,932
+80% +$12.7M 0.71% 44
2020
Q3 		$16.4M Buy
518,054
+159,819
+45% +$5.29M 0.62% 45
2020
Q2 		$12.8M Buy
358,235
+68,457
+24% +$2.38M 0.66% 37
2020
Q1 		$10.7M Buy
289,778
+35,442
+14% +$929K 0.73% 28
2019
Q4 		$6.5M Sell
254,336
-195,988
-44% -$4.39M 0.42% 80
2019
Q3 		$10.5M Sell
450,324
-29,990
-6% -$495K 0.9% 25
2019
Q2 		$7.53M Buy
480,314
+176,796
+58% +$3.48M 0.59% 61
2019
Q1 		$6.91M Sell
303,518
-59,969
-16% -$1.35M 0.55% 57
2018
Q4 		$8.45M Sell
363,487
-122,006
-25% -$3.26M 0.82% 46
2018
Q3 		$16M Buy
485,493
+81,648
+20% +$3.05M 0.98% 39
2018
Q2 		$17.8M Buy
403,845
+108,822
+37% +$4.21M 1.12% 26
2018
Q1 		$12.3M Sell
295,023
-32,336
-10% -$1.49M 1.16% 23
2017
Q4 		$14.9M Buy
327,359
+207,331
+173% +$8.17M 1.96% 10
2017
Q3 		$3.98M Buy
120,028
+42,860
+56% +$1.74M 0.95% 22
2017
Q2 		$3.13M Buy
77,168
+61,189
+383% +$1.9M 1.13% 17
2017
Q1 		$321K Buy
15,979
+7,045
+79% +$149K 0.03% 138
2016
Q4 		$206K Buy
8,934
+4,804
+116% +$103K 0.02% 195
2016
Q3 		$83K Buy
4,130
+166
+4% +$3.35K 0.01% 306
2016
Q2 		$74K Buy
+3,964
New +$72.8K 0.01% 231

Other funds holding PETS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

Penserra Capital Management's PETS Position: Q3 2023 in Review

Penserra Capital Management sold out of PetMed Express (PETS) in Q3 2023, closing a stake of 267,108 shares — an estimated $3.68M sold.

Penserra Capital Management first reported a position in PETS in Q2 2016 and held it in 29 quarters. The position peaked at $34.7M in Q1 2021. 139 funds tracked by Wall St. Rank hold PETS as of Q3 2023.

  • Penserra Capital Management reported no remaining PetMed Express position as of Q3 2023 after selling out during the quarter.
  • Penserra Capital Management sold 267,108 PetMed Express shares in Q3 2023, an estimated $3.68M.
  • Penserra Capital Management first reported a position in PetMed Express in Q2 2016 and held it in 29 quarters.
  • Penserra Capital Management's PetMed Express position peaked at $34.7M in Q1 2021.
  • 139 funds tracked by Wall St. Rank held PetMed Express as of Q3 2023.

Based on Penserra Capital Management's 13F filing for Q3 2023, filed 15 Nov 2023.